[Significance of silent myocardial ischemia for identification and optimal therapy of patients with latent coronary heart disease. Is there a marker for prognostic indication for PTCA?].
Although percutaneous transluminal coronary angioplasty (PTCA) improves the symptomatic status and exercise capacity of patients with coronary artery disease and stale or unstable angina pectoris, a beneficial effect on long-term prognosis has not been convincingly demonstrated so far. In totally asymptomatic patients with coronary artery disease, however, decision to undertake PTCA is greatly influenced by prognostic considerations. Usually, detection of silent myocardial ischemia in non-invasive examinations (exercise stress testing, ambulatory electrocardiographic monitoring) precedes the angiographic diagnosis of coronary artery disease in these patients.
Hering
D
D
Herz- und Diabeteszentrum Nordrhein-Westfalen, Kardiologische Klinik, Ruhr-Universität Bochum, Bad Oeynhausen.
Schultheiss
H P
HP
Horstkotte
D
D
D000787:Angina Pectoris / Q000175:diagnosis / Q000628:therapy*; D000789:Angina, Unstable / Q000175:diagnosis / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary; D003327:Coronary Disease / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D017202:Myocardial Ischemia / Q000175:diagnosis / Q000628:therapy*; D009204:Myocardial Revascularization; D011379:Prognosis; D016896:Treatment Outcome